Why Neuromodulation Devices Face Great Promise – and Challenges – for Growth in EMEA Markets episode artwork

EPISODE · May 9, 2025 · 52 MIN

Why Neuromodulation Devices Face Great Promise – and Challenges – for Growth in EMEA Markets

from DeviceTalks Podcast Network · host DeviceTalks Podcast Network

In this episode of the DeviceTalks Weekly Podcast, Vincent Sourdaine, vice president of neuromodulation for EMEA, shares his journey into the MedTech industry and his fascination with neurotechnologies. Overseeing product launches in over 100 countries, he discusses the deep need for pain relief and other benefits of neuromodulation, and the challenges presented by EMEA’s unique health care markets. This episode is sponsored by DeviceTalks Minnesota. Go to Minnesota.DeviceTalks.com to register. Use the discount code mentioned in the episode. But we’ll start off the episode with MassDevice Editor Chris Newmarker’s #NewmarkersNewsmakers including Cardinal Health, AdvaMed, Zimmer Biomet, EndoGenex, HistoSonics, and orthopedic companies. Go to MassDevice.com for our medical device coverage. Thank you for listening to this episode of the DeviceTalks Weekly Podcast. Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Episode metadata supplied by the publisher feed · Published May 9, 2025

Embed this episode

NOW PLAYING

Why Neuromodulation Devices Face Great Promise – and Challenges – for Growth in EMEA Markets

0:00 52:00

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of DeviceTalks Podcast Network?

This episode is 52 minutes long.

When was this DeviceTalks Podcast Network episode published?

This episode was published on May 9, 2025.

Can I download this DeviceTalks Podcast Network episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!